Context Therapeutics (CNTX) stock Forecast for 2022 – 2026
Last update: March 23, 2023 (18:19)
Sector: HealthcareThe share price of Context Therapeutics Inc. (CNTX) now
50/200 Day Moving Average: $0.789 / $1.35
This figure corresponds to the Average Price over the previous 50/200 days. For Context Therapeutics stocks, the 50-day moving average is the resistance level today.
For Context Therapeutics stocks, the 200-day moving average is the resistance level today.
Are you interested in Context Therapeutics Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Context Therapeutics stock price in 2023, 2024, 2025, 2026, 2027. How much will one Context Therapeutics share be worth in 2023 - 2027?
When should I take profit in Context Therapeutics stock? When should I record a loss on Context Therapeutics stock? What are analysts' forecasts for Context Therapeutics stock? What is the future of Context Therapeutics stock? We forecast Context Therapeutics stock performance using neural networks based on historical data on Context Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Context Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Context Therapeutics shares. This happens once a day.
Historical and forecast chart of Context Therapeutics stock
The chart below shows the historical price of Context Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Context Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Context Therapeutics daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Mar 25 | 0.69 | 0.67 | 0.71 | 6.86 |
| Mar 26 | 0.70 | 0.69 | 0.72 | 4.25 |
| Mar 27 | 0.67 | 0.65 | 0.70 | 6.49 |
| Mar 28 | 0.68 | 0.66 | 0.69 | 4.43 |
| Mar 29 | 0.69 | 0.67 | 0.71 | 7.16 |
| Mar 30 | 0.70 | 0.67 | 0.73 | 8.13 |
| Mar 31 | 0.70 | 0.69 | 0.73 | 6.21 |
| Apr 01 | 0.71 | 0.68 | 0.72 | 6.37 |
| Apr 02 | 0.70 | 0.69 | 0.73 | 5.56 |
| Apr 03 | 0.72 | 0.68 | 0.74 | 8.29 |
| Apr 04 | 0.71 | 0.70 | 0.74 | 5.42 |
| Apr 05 | 0.70 | 0.69 | 0.71 | 3.42 |
| Apr 06 | 0.74 | 0.71 | 0.76 | 6.15 |
| Apr 07 | 0.78 | 0.77 | 0.81 | 5.12 |
| Apr 08 | 0.76 | 0.74 | 0.78 | 6.68 |
| Apr 09 | 0.76 | 0.75 | 0.77 | 3.29 |
| Apr 10 | 0.77 | 0.76 | 0.80 | 5.31 |
| Apr 11 | 0.78 | 0.76 | 0.82 | 7.40 |
| Apr 12 | 0.79 | 0.77 | 0.83 | 8.07 |
| Apr 13 | 0.80 | 0.76 | 0.83 | 8.71 |
| Apr 14 | 0.81 | 0.78 | 0.84 | 8.65 |
| Apr 15 | 0.83 | 0.79 | 0.84 | 5.75 |
| Apr 16 | 0.81 | 0.80 | 0.83 | 4.07 |
| Apr 17 | 0.84 | 0.80 | 0.87 | 8.00 |
| Apr 18 | 0.86 | 0.84 | 0.90 | 7.27 |
| Apr 19 | 0.85 | 0.82 | 0.89 | 8.79 |
| Apr 20 | 0.87 | 0.84 | 0.91 | 8.25 |
| Apr 21 | 0.88 | 0.86 | 0.90 | 4.84 |
| Apr 22 | 0.86 | 0.83 | 0.90 | 8.69 |
| Apr 23 | 0.82 | 0.80 | 0.85 | 5.66 |
Context Therapeutics Daily Price Targets
Context Therapeutics Stock Forecast 03-25-2023.
Forecast target price for 03-25-2023: $0.69.
Positive dynamics for Context Therapeutics shares will prevail with possible volatility of 6.421%.
Pessimistic target level: 0.67
Optimistic target level: 0.71
Context Therapeutics Stock Forecast 03-26-2023.
Forecast target price for 03-26-2023: $0.70.
Positive dynamics for Context Therapeutics shares will prevail with possible volatility of 4.078%.
Pessimistic target level: 0.69
Optimistic target level: 0.72
Context Therapeutics Stock Forecast 03-27-2023.
Forecast target price for 03-27-2023: $0.67.
Negative dynamics for Context Therapeutics shares will prevail with possible volatility of 6.093%.
Pessimistic target level: 0.65
Optimistic target level: 0.70
Context Therapeutics Stock Forecast 03-28-2023.
Forecast target price for 03-28-2023: $0.68.
Positive dynamics for Context Therapeutics shares will prevail with possible volatility of 4.239%.
Pessimistic target level: 0.66
Optimistic target level: 0.69
Context Therapeutics Stock Forecast 03-29-2023.
Forecast target price for 03-29-2023: $0.69.
Positive dynamics for Context Therapeutics shares will prevail with possible volatility of 6.680%.
Pessimistic target level: 0.67
Optimistic target level: 0.71
Context Therapeutics Stock Forecast 03-30-2023.
Forecast target price for 03-30-2023: $0.70.
Positive dynamics for Context Therapeutics shares will prevail with possible volatility of 7.521%.
Pessimistic target level: 0.67
Optimistic target level: 0.73
CNTX (CNTX) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Apr. | 0.64 | 0.60 | 0.69 | 13.94 |
| May. | 0.71 | 0.68 | 0.76 | 9.98 |
| Jun. | 0.74 | 0.67 | 0.79 | 14.93 |
| Jul. | 0.67 | 0.59 | 0.75 | 21.71 |
| Aug. | 0.66 | 0.58 | 0.74 | 22.00 |
| Sep. | 0.61 | 0.51 | 0.67 | 23.03 |
| Oct. | 0.66 | 0.60 | 0.76 | 20.77 |
| Nov. | 0.71 | 0.61 | 0.82 | 25.22 |
| Dec. | 0.66 | 0.61 | 0.73 | 16.31 |
Context Therapeutics forecast for this year
Context Therapeutics Stock Prediction for Apr 2023
An downtrend is forecast for this month with an optimal target price of $0.643095. Pessimistic: $0.60. Optimistic: $0.69
Context Therapeutics Stock Prediction for May 2023
An uptrend is forecast for this month with an optimal target price of $0.713835. Pessimistic: $0.68. Optimistic: $0.76
Context Therapeutics Stock Prediction for Jun 2023
An uptrend is forecast for this month with an optimal target price of $0.735251. Pessimistic: $0.67. Optimistic: $0.79
Context Therapeutics Stock Prediction for Jul 2023
An downtrend is forecast for this month with an optimal target price of $0.667607. Pessimistic: $0.59. Optimistic: $0.75
Context Therapeutics Stock Prediction for Aug 2023
An downtrend is forecast for this month with an optimal target price of $0.664937. Pessimistic: $0.58. Optimistic: $0.74
Context Therapeutics Stock Prediction for Sep 2023
An downtrend is forecast for this month with an optimal target price of $0.610412. Pessimistic: $0.51. Optimistic: $0.67
Context Therapeutics Stock Prediction for Oct 2023
An uptrend is forecast for this month with an optimal target price of $0.664128. Pessimistic: $0.60. Optimistic: $0.76
Context Therapeutics Stock Prediction for Nov 2023
An uptrend is forecast for this month with an optimal target price of $0.705304. Pessimistic: $0.61. Optimistic: $0.82
Context Therapeutics Stock Prediction for Dec 2023
An downtrend is forecast for this month with an optimal target price of $0.657344. Pessimistic: $0.61. Optimistic: $0.73
Context Therapeutics (CNTX) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.73 | 0.64 | 0.81 | 20.61 |
| Feb | 0.63 | 0.55 | 0.72 | 22.96 |
| Mar | 0.62 | 0.52 | 0.68 | 22.99 |
| Apr | 0.74 | 0.71 | 0.85 | 16.70 |
| May | 0.77 | 0.69 | 0.89 | 22.18 |
| Jun | 0.81 | 0.69 | 0.92 | 24.47 |
| Jul | 0.89 | 0.85 | 0.99 | 13.56 |
| Aug | 0.89 | 0.77 | 1.01 | 23.81 |
| Sep | 1.00 | 0.90 | 1.15 | 21.97 |
| Oct | 1.06 | 0.91 | 1.23 | 25.69 |
| Nov | 0.95 | 0.84 | 1.03 | 18.03 |
| Dec | 0.92 | 0.84 | 1.06 | 20.97 |
Context Therapeutics (CNTX) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.84 | 0.75 | 0.91 | 17.61 |
| Feb | 0.79 | 0.69 | 0.91 | 24.48 |
| Mar | 0.85 | 0.80 | 0.93 | 13.53 |
| Apr | 0.89 | 0.84 | 1.01 | 17.02 |
| May | 0.93 | 0.88 | 1.06 | 17.11 |
| Jun | 0.97 | 0.93 | 1.10 | 15.40 |
| Jul | 1.03 | 0.89 | 1.08 | 17.40 |
| Aug | 0.99 | 0.86 | 1.04 | 16.73 |
| Sep | 1.06 | 0.93 | 1.13 | 17.67 |
| Oct | 0.86 | 0.79 | 0.92 | 14.37 |
| Nov | 0.96 | 0.88 | 1.05 | 16.30 |
| Dec | 1.09 | 1.03 | 1.21 | 14.59 |
Context Therapeutics (CNTX) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.99 | 0.89 | 1.04 | 14.10 |
| Feb | 1.04 | 0.97 | 1.11 | 12.95 |
| Mar | 1.14 | 1.08 | 1.32 | 17.71 |
| Apr | 1.07 | 0.95 | 1.13 | 16.26 |
| May | 1.09 | 1.02 | 1.20 | 14.94 |
| Jun | 1.15 | 1.08 | 1.29 | 16.40 |
| Jul | 1.16 | 1.10 | 1.31 | 16.11 |
| Aug | 1.05 | 0.97 | 1.12 | 13.67 |
| Sep | 1.13 | 1.08 | 1.21 | 10.13 |
| Oct | 1.02 | 0.89 | 1.13 | 21.48 |
| Nov | 0.98 | 0.93 | 1.06 | 12.29 |
| Dec | 0.93 | 0.85 | 1.06 | 19.51 |
Context Therapeutics (CNTX) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.08 | 0.92 | 1.16 | 20.52 |
| Feb | 1.09 | 1.03 | 1.14 | 9.41 |
| Mar | 1.01 | 0.90 | 1.16 | 22.26 |
| Apr | 1.15 | 0.97 | 1.28 | 24.46 |
| May | 1.32 | 1.11 | 1.45 | 23.59 |
| Jun | 1.18 | 1.12 | 1.32 | 14.75 |
| Jul | 1.18 | 1.06 | 1.34 | 21.09 |
| Aug | 1.13 | 0.96 | 1.22 | 21.22 |
| Sep | 1.22 | 1.03 | 1.41 | 26.64 |
| Oct | 1.16 | 1.08 | 1.21 | 11.11 |
| Nov | 1.11 | 1.06 | 1.19 | 10.67 |
| Dec | 1.27 | 1.14 | 1.44 | 20.74 |
Context Therapeutics information and performance
Context Therapeutics is a clinical-stage American biotechnology company that develops drugs for the treatment of cancer in women. In particular, the therapeutic focus of the company’s candidate drugs is directed towards breast cancer as well as gynecological oncology. In the clinical stage, Context Therapeutics has two directions: it is a drug for the prevention and treatment of ovarian, endometrial and breast cancer ONA-XR and the Claudin 6 program, which is a stage for the study of a bispecific monoclonal antibody against CD3 x anti-Claudin 6 (CLDN6) antigen ( bsAbs).
3675 MARKET STREET, SUITE 200, PHILADELPHIA, PA, US
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Related stocks from Healthcare sector
